Neuropsychology and Anxiety Drugs - Report Example

Depression and anxiety are a branch of psychology that deals with the brain. In most cases, the two conditions occur simultaneously. According to (Bauer et. all 2012) research shows that neuropsychology and anxiety drugs have been used to treat various symptoms which are experienced by patients experiencing certain symptoms such as sleep problems, shortness of breath, heart palpitations, dry mouth, and nausea(World Health Organization, 2012). Medications such as the SSRIs (Selective Serotonin Reuptake Inhibitors) which are responsible for preventing the reuptake of Serotonin by certain brain nerve cells helps to improve mood. The Benzodiazepines work by reducing anxiety by relaxing the muscles.

Antidepressants have proven very effective in dealing with anxiety disorder in most patients. Alprazolam or otherwise known as Xanax and Ativan which are benzodiazepines are examples of antidepressants that are used by anxiety patients (Scule & Ruppertcht, 2014). Lyrical and Gabapentin are anticonvulsant drugs that are also used to treat anxiety symptoms and disorders.

These drugs provide the patients who suffer from both anxiety disorder and depression a wider variety of options to choose from (Kessler et. all, 2012).It, however, should be noted that these drugs should only be administered under a qualified medical doctor prescription. The doctor should be the one to determine the drugs that are right for the patient.

The side effects of using these drugs do vary depending on the person and the condition that they have. The side effects are unique to each drug.( Anderson et. All, 2012).Some benzodiazepines like the ones mentioned earlier have been known to require higher doses as one progresses, therefore, increasing addiction among its users. It is therefore recommended in small doses to reduce the chances of addiction (Correll et. all, 2015).

References

Anderson, H. D., Pace, W. D., Libby, A. M., West, D. R., & Valuck, R. J. (2012). Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: the retrospective US claims study. Clinical Therapeutics, 34(1), 113-123.

Bauer, R. M., Iverson, G. L., Cernich, A. N., Binder, L. M., Ruff, R. M., & Naugle, R. I. (2012). Computerized neuropsychological assessment devices: joint position paper of the American Academy of Clinical Neuropsychology and the National Academy of Neuropsychology. Archives of Clinical Neuropsychology, 27(3), 362-373

Correll, C. U., Detraux, J., De Lepeleire, J., & De Hert, M. (2015). Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry, 14(2), 119-136.

Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. U. (2012). Twelvemonth and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. International journal of methods in psychiatric research, 21(3), 169-184.

Schule, C., Nothdurfter, C., & Rupprecht, R. (2014). The role of allopregnanolone in depression and anxiety. Progress in neurobiology, 113, 79-87.